S

Soleno Therapeutics
D

SLNO

41.370
USD
2.23
(5.70%)
مفتوح الان
حجم التداول
40,825
الربح لكل سهم
5
العائد الربحي
-
P/E
-24
حجم السوق
2,227,354,737
أصول ذات صلة المقالات

العنوان: Soleno Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulationof a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.